ARVO 2013 Wrap-up: Noteworthy Retinal News
Dr. Kuppermann: In addition, there are other exciting technologies, particularly those from Massachusetts Institute of Technology (MIT) and California Institute of Technology (Caltech), the most impressive technology institutions in America. It is now possible to perform whole-eye OCT, in which you can scan the cornea -- the entire eye -- and the retina in a single scan. It is quite a remarkable reconstruction, mind-boggling in its detail and depth. Our fields are becoming even more closely linked as we are able to perform imaging of the entire eye. This work, from MIT, has ramifications for how these techniques are done, and also for remote telemedicine.
Separately, at Caltech, they are working on OCT that is miniaturized so that you can put it in a probe inside the eye. One direction that OCT imaging is taking is intraoperative applications. OCT scanners are being built that can be mounted to an operating microscope to obtain OCT images during surgery. It permits a scan of the retina to be viewed midsurgery, allowing the surgeon to continue operating and decide, for example, whether to remove the entire epiretinal membrane. This probe is so small, and it can be put directly in the eye during surgery and coupled to the light source to provide continuous OCT monitoring. It has a smaller zone and allows real-time OCT while you are operating, and visualization of features of the vitreous interacting with the retina and details of the retinal surface in terms of epiretinal membrane.
There is a huge amount of interest in this fascinating imaging technology that is revolutionizing the care of retina in the operating room setting in a very clever fashion. Amazingly, this OCT has been miniaturized to a 22- to 23-gauge probe size that can be placed in the eye, allowing you to visualize features of the vitreous interacting with the retina and details of the retinal surface and epiretinal membrane.
Dr. Steinert: I can guarantee that there will be plenty of anterior segment interest in that as well, for all of the areas that we cannot see effectively but which affect anterior segment pathology.
Whole-Eye and Intraoperative OCT
Dr. Kuppermann: In addition, there are other exciting technologies, particularly those from Massachusetts Institute of Technology (MIT) and California Institute of Technology (Caltech), the most impressive technology institutions in America. It is now possible to perform whole-eye OCT, in which you can scan the cornea -- the entire eye -- and the retina in a single scan. It is quite a remarkable reconstruction, mind-boggling in its detail and depth. Our fields are becoming even more closely linked as we are able to perform imaging of the entire eye. This work, from MIT, has ramifications for how these techniques are done, and also for remote telemedicine.
Separately, at Caltech, they are working on OCT that is miniaturized so that you can put it in a probe inside the eye. One direction that OCT imaging is taking is intraoperative applications. OCT scanners are being built that can be mounted to an operating microscope to obtain OCT images during surgery. It permits a scan of the retina to be viewed midsurgery, allowing the surgeon to continue operating and decide, for example, whether to remove the entire epiretinal membrane. This probe is so small, and it can be put directly in the eye during surgery and coupled to the light source to provide continuous OCT monitoring. It has a smaller zone and allows real-time OCT while you are operating, and visualization of features of the vitreous interacting with the retina and details of the retinal surface in terms of epiretinal membrane.
There is a huge amount of interest in this fascinating imaging technology that is revolutionizing the care of retina in the operating room setting in a very clever fashion. Amazingly, this OCT has been miniaturized to a 22- to 23-gauge probe size that can be placed in the eye, allowing you to visualize features of the vitreous interacting with the retina and details of the retinal surface and epiretinal membrane.
Dr. Steinert: I can guarantee that there will be plenty of anterior segment interest in that as well, for all of the areas that we cannot see effectively but which affect anterior segment pathology.
SHARE
